Drawing for MEDISENS

USPTO serial 79382733

MEDISENS

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
SABAGH, LAILA TAREK
Law office
TMO LAW OFFICE 127

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with MEDISENS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Babies' diapers; incontinence diapers; babies' diaper-pants; incontinence diapers; adult napkins; incontinence and baby napkins and diapers and incontinence pads with equipment for detecting, testing and measuring body fluids, not related to diabetesACTIVE—
009Apparatus for measuring, detecting, monitoring and analysing body fluids; software; applications for mobile devices; computer programs and applications for uploading, measuring and monitoring health information; computer programs and applications for uploading, measuring and monitoring information about body fluids; apparatus and monitoring systems for collecting data relating to incontinence and health; apparatus and monitoring systems for collecting data about body fluids; Computer software for use with wireless medical monitoring systems; portable apparatus for attachment to babies' and adult napkins and incontinence products and incontinence and medical sheets, which can measure, detect, monitor and analyze body fluids; None of the aforementioned goods being related to diabetesACTIVE—
010Diagnostic apparatus and equipment for medical purposes for babies' and adult napkins and for incontinence products and for incontinence sheets and for medical absorbent sheets; equipment, devices and instruments for detecting, collecting, testing and measuring body fluids for medical purposes used in connection to babies' and adult napkins and for incontinence products and for incontinence and medical sheets; medical devices, equipment and instruments for collecting information about body fluids used in connection to babies' and adult napkins and in connection to incontinence products and medical and incontinence sheets; diagnostic apparatus and medical devices for incorporation in or attachment to babies' and adult napkins; diagnostic apparatus and medical devices for incorporation in or attachment to incontinence products and medical and incontinence sheets for detecting, collecting, analysing or testing body fluids; portable medical devices and instruments for attachment to babies' and adult napkins and incontinence products and incontinence and medical sheets, which can collect information about body fluids; portable devices and instruments for attachment to babies' and adult napkins and incontinence products and incontinence and medical sheets, which can detect body fluids and collect information about body fluids; Incontinence sheets; Incontinence sheets with equipment for detecting, testing and measuring body fluids; medical absorbent sheets; medical absorbent sheets with equipment for detecting, testing and measuring body fluids; Wireless medical monitoring device for monitoring and detection of patient bed and diaper wetness; Wireless medical monitoring platforms for monitoring and detection of patient bed and diaper wetness; None of the aforementioned goods being related to diabetesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 26, 2025OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Apr 8, 2025OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Apr 8, 2025OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Apr 1, 2025MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Apr 1, 2025ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Feb 27, 2024RFNTREFUSAL PROCESSED BY IB—
Feb 2, 2024RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Feb 2, 2024RFRRREFUSAL PROCESSED BY MPU—
Jan 18, 2024RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jan 17, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 10, 2024DOCKASSIGNED TO EXAMINER—
Nov 18, 2023MAFRAPPLICATION FILING RECEIPT MAILED—
Nov 14, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 9, 2023REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance